Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury


Phase 1/2 Results N/A

Summary of Purpose

The purpose of our study is to determine the safety and efficacy of the combination of erythropoietin (EPO) and granulocyte-colony stimulating factors (G-CSF) in patients with neurological diseases. To be specific, our clinical study is expected that the combination injection of EPO and G-CSF shows neurotrophic and neuroprotective effects by facilitating endogenous repair process in patients with neurological...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 July 2014.

1 Dec 2013 30 Oct 2013 1 Dec 2015 1 Dec 2015 1 Jul 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment